We're debuting a new look. See the updated format below. You'll now receive two short newsletters each month on the latest in the field of focused ultrasound.
Focused ultrasound researchers worldwide are making unprecedented progress in addressing the unmet need of providing life-extending treatment for patients with deadly brain tumors – glioblastoma multiforme (GBM). Most recently, a new clinical trial has begun in Korea, and the results of a first-in-human study in Toronto were published. A number of other clinical firsts in this area have occurred in the past several months.
We are pleased to announce that four professionals with a wide array of expertise have joined the Foundation’s Council, a dedicated group of goodwill ambassadors.
Please browse our new website, highlighting the people essential to our mission of advancing focused ultrasound: the patients, experts, donors, and industry leaders.
In October, neurosurgeon Ali Rezai, MD, began the first US focused ultrasound trial for Alzheimer’s disease. Here, he discusses the patient’s progress and his plans for the future.
A 30-patient Alzheimer’s disease trial using focused ultrasound to open the blood-brain barrier in multiple regions has begun at Sunnybrook Health Sciences Centre.
Submit your abstracts for the joint meeting of the European Focused Ultrasound Charitable Society (EUFUS) and the International Society for Therapeutic Ultrasound (ISTU).
A companion paper illustrating the clinical significance and utility of a 2018 focused ultrasound plus ThermoDox liver cancer trial was published in Radiology.
The University of Michigan's Mario Fabiilli, PhD, and Renny Franceschi, PhD, used focused ultrasound to trigger heat-activated, gene-switching cells to control bone regeneration.
